hotspot -WSS

hotspot

author：leisure time 2025-09-30 13:13:59 - browse：5

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Takeda, Janssen join wearable maker to measure scratching

hotspot

WSS

UnitedHealth’s Optum accused of antitrust violations in California

UnitedHealth’s Optum accused of antitrust violations in California

CDC marks new Covid

NEJM study link tiny plastics in blood vessels to heart problems

Headspace, Meta partner to launch VR meditation app for Quest

NEJM study link tiny plastics in blood vessels to heart problems

focus

hotspot

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Organ aging and disease risk measured by new blood test

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Amylyx ALS drug failure raises questions and concerns

Moonlake's readout produced a cash windfall. Risks remain

Just how do doctors, lawmakers, and the public define abortion?

ChatGPT in medicine: STAT answers readers' burning questions

As biotech industry slumps, bioscience job market is upside down

Medical records are filled with copy

Despite FDA concern, risk that CAR

hotspot

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

CDC director unscathed in first congressional testimony

U.K. Biobank has 500,000 peoples' genome sequences available

Amylyx ALS drug fails large clinical trial

FDA investigates CAR

Novo Nordisk obesity pill bests Wegovy in early trial

entertainment

knowledge

hotspot

explore